Growth Metrics

Trulieve Cannabis (TCNNF) Capital Expenditures (2020 - 2026)

Trulieve Cannabis has reported Capital Expenditures over the past 6 years, most recently at $2.3 million for Q3 2025.

  • For Q3 2025, Capital Expenditures fell 96.92% year-over-year to $2.3 million; the TTM value through Dec 2025 reached $3.7 million, down 96.97%, while the annual FY2025 figure was $3.7 million, 96.97% down from the prior year.
  • Capital Expenditures for Q3 2025 was $2.3 million at Trulieve Cannabis, up from -$1.4 million in the prior quarter.
  • Over five years, Capital Expenditures peaked at $189.0 million in Q3 2021 and troughed at -$187.2 million in Q4 2021.
  • A 5-year average of $9.4 million and a median of $2.9 million in 2025 define the central range for Capital Expenditures.
  • Biggest five-year swings in Capital Expenditures: crashed 14611.25% in 2021 and later soared 1581.12% in 2023.
  • Year by year, Capital Expenditures stood at -$187.2 million in 2021, then soared by 101.03% to $1.9 million in 2022, then soared by 1581.12% to $32.5 million in 2023, then skyrocketed by 31.4% to $42.7 million in 2024, then crashed by 94.69% to $2.3 million in 2025.
  • Business Quant data shows Capital Expenditures for TCNNF at $2.3 million in Q3 2025, -$1.4 million in Q2 2025, and $2.9 million in Q1 2025.